Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 170

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Predicting IDH mutation status in grade II gliomas using amide proton transfer‐weighted (APTw) MRI

Open access
Jiang, Shanshan, Zou, Tianyu, Eberhart, Charles G., Villalobos, Maria A.V., Heo, Hye‐Young, Zhang, Yi, Wang, Yu, Wang, Xianlong, Yu, Hao, Du, Yongxing, van Zijl, Peter C.M., Wen, Zhibo, Zhou, Jinyuan·2017·Magnetic Resonance in Medicine

Abstract

Purpose: To assess the amide proton transfer‐weighted (APTw) MRI features of isocitrate dehydrogenase (IDH)‐wildtype and IDH‐mutant grade II gliomas and to test the hypothesis that the APTw signal is a surrogate imaging marker for identifying IDH mutation status preoperatively. Methods: Twenty‐seven patients with pathologically confirmed low‐grade glioma, who were previously scanned at 3T, were retrospectively analyzed. The Mann‐Whitney test was used to evaluate relationships between APTw intensities for IDH‐mutant and IDH‐wildtype groups, and receiver operator characteristic (ROC) analysis was used to assess the diagnostic performance of APTw. Results: Based on histopathology and molecular analysis, seven cases were diagnosed as IDH‐wildtype grade II gliomas and 20 cases as IDH‐mutant grade II gliomas. The maximum and minimum APTw values, based on multiple regions of interest, as well as the whole‐tumor histogram‐based mean and 50th percentile APTw values, were significantly higher in the IDH‐wildtype gliomas than in the IDH‐mutant groups. This corresponded to the areas under the ROC curves of 0.89, 0.76, 0.75, and 0.75, respectively, for the prediction of the IDH mutation status. Conclusion: IDH‐wildtype lesions typically were associated with relatively high APTw signal intensities as compared with IDH‐mutant lesions. The APTw signal could be a valuable imaging biomarker by which to identify IDH1 mutation status in grade II gliomas. Magn Reson Med 78:1100–1109, 2017. © 2017 International Society for Magnetic Resonance in Medicine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/mrm.26820

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 170

Metadata

Authors
Jiang, S., Zou, T., Eberhart, C. G., Villalobos, M. A. V., Heo, H., Zhang, Y., Wang, Y., Wang, X., Yu, H., Du, Y., van Zijl, P. C. M., Wen, Z., & Zhou, J.
Venue
Magnetic Resonance in Medicine
Publisher
Wiley
Published
2017-07-16
Volume
78
Issue
3
Pages
1100-1109
ISSN
  • 0740-3194 (ISSN-L)
  • 1522-2594
OpenAlex
W2734807975
Cited by
170
References
8
FWCI
7.36
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Predicting IDH mutation status in grade II gliomas using amide proton transfer‐weighted (APTw) MRI. https://app.cochat.ai/papers/10.1002/mrm.26820
The paper
Jiang, S., Zou, T., Eberhart, C. G., Villalobos, M. A. V., Heo, H., Zhang, Y., Wang, Y., Wang, X., Yu, H., Du, Y., van Zijl, P. C. M., Wen, Z., & Zhou, J. (2017). Predicting IDH mutation status in grade II gliomas using amide proton transfer‐weighted (APTw) MRI. Magnetic Resonance in Medicine. https://doi.org/10.1002/mrm.26820

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.